1. Home
  2. BNTX vs FCNCA Comparison

BNTX vs FCNCA Comparison

Compare BNTX & FCNCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTX
  • FCNCA
  • Stock Information
  • Founded
  • BNTX 2008
  • FCNCA 1898
  • Country
  • BNTX Germany
  • FCNCA United States
  • Employees
  • BNTX N/A
  • FCNCA N/A
  • Industry
  • BNTX Biotechnology: Biological Products (No Diagnostic Substances)
  • FCNCA Major Banks
  • Sector
  • BNTX Health Care
  • FCNCA Finance
  • Exchange
  • BNTX Nasdaq
  • FCNCA Nasdaq
  • Market Cap
  • BNTX 23.9B
  • FCNCA 29.3B
  • IPO Year
  • BNTX 2019
  • FCNCA N/A
  • Fundamental
  • Price
  • BNTX $114.00
  • FCNCA $2,142.67
  • Analyst Decision
  • BNTX Strong Buy
  • FCNCA Buy
  • Analyst Count
  • BNTX 15
  • FCNCA 10
  • Target Price
  • BNTX $143.50
  • FCNCA $2,252.90
  • AVG Volume (30 Days)
  • BNTX 659.5K
  • FCNCA 86.1K
  • Earning Date
  • BNTX 11-04-2024
  • FCNCA 01-24-2025
  • Dividend Yield
  • BNTX N/A
  • FCNCA 0.36%
  • EPS Growth
  • BNTX N/A
  • FCNCA N/A
  • EPS
  • BNTX N/A
  • FCNCA 174.55
  • Revenue
  • BNTX $3,390,698,192.00
  • FCNCA $9,364,000,000.00
  • Revenue This Year
  • BNTX N/A
  • FCNCA N/A
  • Revenue Next Year
  • BNTX N/A
  • FCNCA N/A
  • P/E Ratio
  • BNTX N/A
  • FCNCA $12.33
  • Revenue Growth
  • BNTX N/A
  • FCNCA 44.77
  • 52 Week Low
  • BNTX $76.53
  • FCNCA $1,363.97
  • 52 Week High
  • BNTX $131.49
  • FCNCA $2,388.78
  • Technical
  • Relative Strength Index (RSI)
  • BNTX 48.71
  • FCNCA 50.98
  • Support Level
  • BNTX $109.52
  • FCNCA $2,024.01
  • Resistance Level
  • BNTX $115.34
  • FCNCA $2,159.61
  • Average True Range (ATR)
  • BNTX 4.24
  • FCNCA 51.23
  • MACD
  • BNTX -0.72
  • FCNCA -2.82
  • Stochastic Oscillator
  • BNTX 27.24
  • FCNCA 66.72

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

About FCNCA First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank & Trust Company. FCB was founded as the Bank of Smithfield in North Carolina and has expanded through both de novo branching and acquisitions. FCB currently operates in nearly half of the continental United States, but principally takes deposits in the Carolinas. The bank's operations have historically been influenced by the Holding family, which has traditionally held executive and director positions, as well as controlling a large percentage of its outstanding stock. FCB provides a wide range of retail and commercial banking services, including traditional lending and deposit-taking, as well as trust and wealth management. FCB's main source of revenue is net interest income.

Share on Social Networks: